Evidence map›Paper›PMID 27043495›Full record

ArticleNature medicine2016

Inflammatory signaling in human tuberculosis granulomas is spatially organized.

Mohlopheni J Marakalala, Ravikiran M Raju, Kirti Sharma, Yanjia J Zhang, Eliseo A Eugenin, Brendan Prideaux, Isaac B Daudelin, Pei-Yu Chen, Matthew G Booty, Jin Hee Kim and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed, 2 pooled it
23.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 2 syntheses or guidelines pooled it, 299 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Mohlopheni J MarakalalaDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0001-7476-1652
Ravikiran M RajuDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Kirti SharmaDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Yanjia J ZhangDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Eliseo A EugeninPublic Health Research Institute, New Jersey Medical School, Newark, New Jersey, USA.
Brendan PrideauxPublic Health Research Institute, New Jersey Medical School, Newark, New Jersey, USA.
Isaac B DaudelinPublic Health Research Institute, New Jersey Medical School, Newark, New Jersey, USA.ORCID 0000-0001-7967-1162
Pei-Yu ChenPublic Health Research Institute, New Jersey Medical School, Newark, New Jersey, USA.
Matthew G BootyDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.ORCID 0000-0002-0835-3439
Jin Hee KimNational Masan TB Hospital, Changwon, Republic of Korea.
Seok Yong EumInternational Tuberculosis Research Center, Changwon, Republic of Korea.
Laura E ViaTuberculosis Research Section, Laboratory of Clinical Infectious Disease, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Samuel M BeharDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Clifton E BarryTuberculosis Research Section, Laboratory of Clinical Infectious Disease, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Matthias MannDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Véronique DartoisPublic Health Research Institute, New Jersey Medical School, Newark, New Jersey, USA.
Eric J RubinDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Harvard University · USRutgers New Jersey Medical School · USMax Planck Institute of Biochemistry · DENational Institutes of Health · USRutgers, The State University of New Jersey · USInternational Tuberculosis Research Center · KRMasan National Tuberculosis Hospital · KRUniversity of Massachusetts Chan Medical School · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Experimental Animal Models of TB: Chemotherapeutics and ImagingZIAAI000734 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2025
$19.6M
International Research in Korea: Clinical Studies of Drug-Resistant TuberculosisZIAAI001067 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2017
$6.9M
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDSR01MH096625 · NIMH · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI EUGENIN, ELISEO A · 2012 to 2020
$4.5M
Role of pannexin-1 hemichannels in NeuroAIDSR01NS105584 · NINDS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI EUGENIN, ELISEO A · 2017 to 2021
$3.2M
Apoptosis and efferocytosis: regulators of immunity to tuberculosisR01AI098637 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BEHAR, SAMUEL M · 2012 to 2016
$2.4M
The temporal reconfiguration of regulatory networks: From yeast to cancerDP1CA174427 · NCI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2012 to 2012
$839k
A MALDI LTQ Orbitrap XL Mass Spectrometer for BioImagingS10OD018072 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI DARTOIS, VERONIQUE · 2015 to 2015
$418k
Howard Hughes Medical InstituteNCI NIH HHS DP1 CA174427NIAID NIH HHS R01 AI098637NIGMS NIH HHS T32 GM007753NIH HHS S10 OD018072NIMH NIH HHS R01 MH096625NINDS NIH HHS R01 NS105584
6 · The paper itself

Abstract

Granulomas are the pathological hallmark of tuberculosis (TB). However, their function and mechanisms of formation remain poorly understood. To understand the role of granulomas in TB, we analyzed the proteomes of granulomas from subjects with tuberculosis in an unbiased manner. Using laser-capture microdissection, mass spectrometry and confocal microscopy, we generated detailed molecular maps of human granulomas. We found that the centers of granulomas have a pro-inflammatory environment that is characterized by the presence of antimicrobial peptides, reactive oxygen species and pro-inflammatory eicosanoids. Conversely, the tissue surrounding the caseum has a comparatively anti-inflammatory signature. These findings are consistent across a set of six human subjects and in rabbits. Although the balance between systemic pro- and anti-inflammatory signals is crucial to TB disease outcome, here we find that these signals are physically segregated within each granuloma. From the protein and lipid snapshots of human and rabbit lesions analyzed here, we hypothesize that the pathologic response to TB is shaped by the precise anatomical localization of these inflammatory pathways during the development of the granuloma.

Indexed as

AnimalsArachidonic AcidEicosanoidsGranulomaHumansImmunohistochemistryInflammationLaser Capture MicrodissectionMass SpectrometryMicroscopy, ConfocalProteomicsRabbitsReactive Oxygen SpeciesSignal TransductionSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTuberculosis, PulmonaryArachidonic AcidEicosanoidsReactive Oxygen Species

Identifiers

PMID27043495
PMCPMC4860068
OpenAlexW2326834550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.